Validation of a specific measure to assess health-related quality of life in patients with schizophrenia and bipolar disorder: the 'Tolerability and quality of life' (TOOL) questionnaire

被引:6
作者
Montejo, Angel L. [1 ]
Lauffer, Javier Correas [2 ]
Cuervo, Jesus [3 ]
Rebollo, Pablo [3 ]
Cordero, Luis [4 ]
Diez, Teresa [5 ]
Maurino, Jorge [5 ]
机构
[1] Hosp Univ Salamanca, Dept Psychiat, Salamanca, Spain
[2] Hosp Henares, Dept Psychiat, Madrid, Spain
[3] BAP Hlth Outcomes Res, Oviedo, Spain
[4] AstraZeneca Med Dept, Value Demonstrat Unit, Madrid, Spain
[5] AstraZeneca Med Dept, Neurosci Area, Madrid, Spain
关键词
SCALE; RELIABILITY; VALIDITY; ANTIPSYCHOTICS; EXPERIENCE; OUTCOMES; THERAPY; MANIA; EQ-5D;
D O I
10.1186/1744-859X-10-6
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Background: Perception of quality of life may differ depending on the perspective. The aim of the study was to assess the psychometric properties of the Spanish version of the 'TOlerability and quality Of Life' (TOOL) questionnaire, a specific self-rated instrument to evaluate the impact of side effects of antipsychotic drugs on health-related quality of life (HRQoL). The questionnaire consists of eight items answered on a four-point Likert scale. Methods: A psychometric study was conducted with clinically stable outpatients with schizophrenia and bipolar disorder under antipsychotic treatment. The translation and cultural adaptation of the questionnaire was performed according to international standards. Internal consistency using the Cronbach a coefficient and test-retest reliability using the intraclass correlation coefficient (ICC) was used to assess the reliability of the instrument. Patients completed generic and specific measures of quality of life and clinical severity. Results: A total of 238 patients were analysed, with a mean age of 42 years (SD 10.9). The mean completion time was 4.9 min (SD 4.4). Internal consistency and intraclass correlation coefficient were adequate (Cronbach alpha = 0.757 and ICC = 0.90). Factorial analysis showed a unidimensional structure (a single eigenvalue > 1, accounting for 39.1% of variance). Significant Spearman's rank correlations between the TOOL and both generic and specific measures were found. The questionnaire was able to discriminate among the Clinical Global Impression - Severity scores (Mann-Whitney U test, P < 0.001). Conclusions: The TOOL questionnaire shows appropriate feasibility, reliability, and discriminative performance as a patient-reported outcome. TOOL constitutes a valuable addition to measure the impact of adverse events of antipsychotic drugs from the patient perspective.
引用
收藏
页数:8
相关论文
共 33 条
[1]   Health-Related Quality of Life (HRQL) and Continuous Antipsychotic Treatment: 3-year Results from the Schizophrenia Health Outcomes (SOHO) Study [J].
Alonso, Jordi ;
Croudace, Tim ;
Brown, Jacqueline ;
Gasquet, Isabelle ;
Knapp, Martin R. J. ;
Suarez, David ;
Novick, Diego .
VALUE IN HEALTH, 2009, 12 (04) :536-543
[2]  
Barberá M, 2006, ACTAS ESP PSIQUIATRI, V34, P287
[3]  
Bobes Julio, 2007, Dialogues Clin Neurosci, V9, P215
[4]   The estimation of a preference-based measure of health from the SF-36 [J].
Brazier, J ;
Roberts, J ;
Deverill, M .
JOURNAL OF HEALTH ECONOMICS, 2002, 21 (02) :271-292
[5]  
Bridle C, 2004, HEALTH TECHNOL ASSES, V8, P1
[6]   Impact of schizophrenia and schizophrenia treatment-related adverse events on quality of life: direct utility elicitation [J].
Briggs, Andrew ;
Wild, Diane ;
Lees, Michael ;
Reaney, Matthew ;
Dursun, Serdar ;
Parry, David ;
Mukherjee, Jayanti .
HEALTH AND QUALITY OF LIFE OUTCOMES, 2008, 6 (1)
[7]  
Buckley PF, 2008, CNS SPECTRUMS, V13, P3
[8]   Spanish version of a scale for the assessment of mania:: validity and reliability of the Young Mania Rating Scale [J].
Colom, F ;
Vieta, E ;
Martínez-Arán, A ;
Garcia-Garcia, M ;
Reinares, M ;
Torrent, C ;
Goikolea, JM ;
Banús, S ;
Salamero, M .
MEDICINA CLINICA, 2002, 119 (10) :366-371
[9]   Tolerability of Atypical Antipsychotics in the Treatment of Adults With Schizophrenia or Bipolar Disorder: A Mixed Treatment Comparison of Randomized Controlled Trials [J].
Edwards, Steven J. ;
Smith, Christopher J. .
CLINICAL THERAPEUTICS, 2009, 31 :1345-1359
[10]   Bipolar Disorder: An Update [J].
El-Mallakh, Rif S. ;
Elmaadawi, Ahmed Z. ;
Loganathan, Muruga ;
Lohano, Kavita ;
Gao, Yonglin .
POSTGRADUATE MEDICINE, 2010, 122 (04) :24-31